Thought it wold be interesting to see the public comments submitted tot he docket for this item. See previous posts where FDA (CDRH) had projected issuing a framework for the validation and review of array CGH assays.
Here is a link to the docket at regulations.gov.
http://www.regulations.gov/#!searchResults;rpp=10;so=DESC;sb=postedDate;po=0;s=FDA-2010-N-0259
There have really only been 2 comments posted from the public.
The College of American Pathologists (http://www.regulations.gov/#!documentDetail;D=FDA-2010-N-0259-0003.1) and
The Cleveland Clinic (http://www.regulations.gov/#!documentDetail;D=FDA-2010-N-0259-0002.1)
The only other items posted are the original Federal Register notice announcing the June 30, 2010 public meeting (http://www.regulations.gov/#!documentDetail;D=FDA-2010-N-0259-0001) and the actual transcript of the public meeting (http://www.regulations.gov/#!documentDetail;D=FDA-2010-N-0259-0004).
Interestingly, FDA does not even seem to have posted the various presentations given at the public meeting to the docket.
No comments:
Post a Comment